RadioPharmaceuticals
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- W81K0025QA122
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Fort Hood, Texas 76544, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of the Army Medical Command is seeking a contractor to provide radiopharmaceuticals for the Nuclear Medicine Service Department at Carl R. Darnall Army Medical Center located at Fort Cavazos, Texas. The solicitation covers various nuclear medicine diagnostic substances including 67 Gallium Citrate, 99m Tc MAG 3, Iodine 131 Capsules, Iodine 123, 99m Tc Sestamibi, 99m Tc Myoview, and other specialized radiopharmaceutical products. Contractors must meet stringent delivery requirements including routine orders delivered by 6:30 AM on weekdays and STAT orders delivered within 1.5 hours during business hours or 2 hours during evenings, weekends, and holidays. The contractor must be accredited by the Joint Commission, ensure dose activity is within 5% of calibrated dose, comply with U.S. Pharmacopeia guidelines, and maintain comprehensive security protocols for facility access. The procurement will use a Lowest Price Technically Acceptable (LPTA) evaluation methodology, with quotes due by July 21, 2025 at 3:30 PM. Amendment 0001, issued on June 26, 2025, confirmed that the Joint Commission accreditation requirement will not be removed from the solicitation.
This procurement is designated as a Women-Owned Small Business (WOSB) set-aside opportunity under NAICS code 325412 for Pharmaceutical Preparation Manufacturing. No information is provided regarding current incumbents or potential contractors for this requirement. While the total contract value is not explicitly stated in the solicitation, the procurement covers multiple radiopharmaceutical line items across both the base year and option periods. The base performance period runs from October 1, 2025 through September 30, 2026, with three additional one-year option periods that could extend the contract through September 30, 2029, representing a potential four-year total contract duration. All services will be performed at Carl R. Darnall Army Medical Center at Fort Cavazos, Texas, with radiopharmaceuticals delivered to a specific location within the medical center's Nuclear Medicine Service Department.
Notice text
2 versions
Update #2 · Latest ·
Amendment 0001 - W81K0025QA122 Posting Date: 26 June 2025.
The purpose of the attached amendment 0001 is to provide answers to questions. Please see amendment 0001.
Solicitation Posting Date: 18 June 2025.
Please see Solicitation W81K0025QA122, for Radiopharmaceuticals for Nuclear Medicine Service Department at Carl R. Darnall Army Medical Center, Ft. Hood, TX 76544. Period of Performance: 1 October 2025 - 30 September 2026 with 3 Option Periods ending 30 September 2029.
Please completely review Standard Form (SF) 1449 / Solicitation W81K0025QA122 for all required Radiopharmaceuticals for base year and all option periods pg. 3-18, Statement of Work (SOW) - Attachment, Addendum 52.212-1 Instructions to Offerors pg.84-86, and 52.212-2 Addendum to Evaluation pg.89-91.
Update #1 ·
Solicitation Posting Date: 18 June 2025.
Please see Solicitation W81K0025QA122, for Radiopharmaceuticals for Nuclear Medicine Service Department at Carl R. Darnall Army Medical Center, Ft. Hood, TX 76544. Period of Performance: 1 October 2025 - 30 September 2026 with 3 Option Periods ending 30 September 2029.
Please completely review Standard Form (SF) 1449 / Solicitation W81K0025QA122 for all required Radiopharmaceuticals for base year and all option periods pg. 3-18, Statement of Work (SOW) - Attachment, Addendum 52.212-1 Instructions to Offerors pg.84-86, and 52.212-2 Addendum to Evaluation pg.89-91.
Files
Notice history
| Notice | Type | Posted |
|---|---|---|
| RadioPharmaceuticals | Award Notice | |
| This notice | Solicitation | |
| Radio-Pharmaceuticals | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052 | Veterans Integrated Service Network 10 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity